Physician

Sreenivasa Basavanthappa, MD

According to 2025 Medicare claims, Sreenivasa Basavanthappa, MD (NPI: 1497953871) practices ophthalmology in the Decatur, IL market, with the plurality of this provider's patient population coming from Macon, IL. This provider's primary affiliated billing organization is GAILEY EYE CLINIC, LTD (NPI: 1932156445; TIN: 370924192) and primary practice location at 62535-1064.

Basavanthappa's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,092 traditional Medicare patients, billed 96,355 HCPCS/CPT codes, and received $4,744,374 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 1,034 prescription claims across 301 beneficiaries totaling $37,887 in drug costs, led by Bromfenac Sodium (Bromfenac Sodium). Open Payments data shows 29 records totaling $676. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $770,670 to $4,744,374. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $44,991 and ending at $37,887. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.4M$4.7M2015 Medicare payment: $770,670 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $995,781 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $624,630 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,169,100 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,066,300 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $587,871 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $877,968 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,436,123 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $3,205,426 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $4,744,374 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20156834,271$770,670
20167525,070$995,781
20175903,092$624,630
20185645,026$1,169,100
20195635,111$1,066,300
20204272,730$587,871
20214494,066$877,968
20225886,467$1,436,123
20231,07844,996$3,205,426
20241,09296,355$4,744,374

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$35K$69K2015 Drug cost: $44,991 (USD; Tot_Drug_Cst)2016 Drug cost: $50,193 (USD; Tot_Drug_Cst)2017 Drug cost: $23,426 (USD; Tot_Drug_Cst)2018 Drug cost: $30,457 (USD; Tot_Drug_Cst)2019 Drug cost: $34,388 (USD; Tot_Drug_Cst)2020 Drug cost: $16,651 (USD; Tot_Drug_Cst)2021 Drug cost: $51,797 (USD; Tot_Drug_Cst)2022 Drug cost: $69,203 (USD; Tot_Drug_Cst)2023 Drug cost: $30,742 (USD; Tot_Drug_Cst)2024 Drug cost: $37,887 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015141431$44,991
2016158507$50,193
201778249$23,426
2018117320$30,457
2019162448$34,388
202087199$16,651
2021150349$51,797
2022201548$69,203
2023210516$30,742
20243011,034$37,887

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye6712,706$82
92014Established patient complete exam of visual system8381,103$79
92012Established patient problem focused exam of visual system282397$63
92134Imaging of retina1,0363,635$29
J2777Injection, faricimab-svoa, 0.1 mg32980,280$27

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Bromfenac SodiumBromfenac Sodium241,050$7,780
Prednisolone AcetatePrednisolone Acetate2047,748$6,868
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol321,505$4,865
Ketorolac TromethamineKetorolac Tromethamine1796,080$3,165
CombiganBrimonidine Tartrate/Timolol12352$2,411

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.29$676ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Sreenivasa Basavanthappa, MD?

Tedicare shows public-source Medicare data for Sreenivasa Basavanthappa, MD (NPI 1497953871), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sreenivasa Basavanthappa, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Sreenivasa Basavanthappa, MD?

Sreenivasa Basavanthappa, MD is linked to GAILEY EYE CLINIC, LTD (billing NPI 1932156445) in the available physician profile data.

Does Sreenivasa Basavanthappa, MD have Open Payments data?

Sreenivasa Basavanthappa, MD has 29 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.